- Home
- Publications
- Publication Search
- Publication Details
Title
S100A7: from mechanism to cancer therapy
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 49, Pages 6749-6761
Publisher
Springer Nature
Online
2017-08-21
DOI
10.1038/onc.2017.283
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psoriasin (S100A7) promotes stress-induced angiogenesis
- (2016) J. Vegfors et al. BRITISH JOURNAL OF DERMATOLOGY
- The role of S100 proteins and their receptor RAGE in pancreatic cancer
- (2015) Estelle Leclerc et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- New horizons in tumor microenvironment biology: challenges and opportunities
- (2015) Fei Chen et al. BMC Medicine
- RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment
- (2015) M. W. Nasser et al. CANCER RESEARCH
- S100A4 promotes liver fibrosis via activation of hepatic stellate cells
- (2015) Lin Chen et al. JOURNAL OF HEPATOLOGY
- Anti-S100A4 Antibody Suppresses Metastasis Formation by Blocking Stroma Cell Invasion
- (2015) Jörg Klingelhöfer et al. NEOPLASIA
- S100 to receptor for advanced glycation end-products binding assay: Looking for inhibitors
- (2014) Laura Padilla et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
- (2014) S R McKeown BRITISH JOURNAL OF RADIOLOGY
- Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15
- (2014) R. Wolf et al. JOURNAL OF IMMUNOLOGY
- S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer
- (2014) S Dakhel et al. Oncogenesis
- From Bevacizumab to Tasquinimod
- (2013) Michael T. Schweizer et al. CANCER JOURNAL
- Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties
- (2013) Ingrid J. Bettum et al. CANCER LETTERS
- Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents
- (2013) Gabriel Limaverde-Sousa et al. CANCER TREATMENT REVIEWS
- Targeting the PDGF signaling pathway in tumor treatment
- (2013) Carl-Henrik Heldin Cell Communication and Signaling
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Alocasia cucullata Exhibits Strong Antitumor Effect In Vivo by Activating Antitumor Immunity
- (2013) Qiuxian Peng et al. PLoS One
- Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody
- (2013) Jose Luis Hernández et al. PLoS One
- Antiangiogenic Therapies: Going beyond Their Limits
- (2013) L. Moserle et al. Cancer Discovery
- Functions of S100 Proteins
- (2012) R. Donato et al. CURRENT MOLECULAR MEDICINE
- ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry
- (2012) Anne-Vibeke Laenkholm et al. Molecular Oncology
- Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation
- (2011) Emman Shubbar et al. BREAST CANCER RESEARCH AND TREATMENT
- S100A7 Enhances Mammary Tumorigenesis through Upregulation of Inflammatory Pathways
- (2011) M. W. Nasser et al. CANCER RESEARCH
- Hepatocyte Growth Factor Induces Resistance to Anti-Epidermal Growth Factor Receptor Antibody in Lung Cancer
- (2011) Tadaaki Yamada et al. Journal of Thoracic Oncology
- S100A14 Stimulates Cell Proliferation and Induces Cell Apoptosis at Different Concentrations via Receptor for Advanced Glycation End Products (RAGE)
- (2011) Qing'e Jin et al. PLoS One
- Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: a potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo?
- (2010) Susann Wolf et al. AMINO ACIDS
- S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer
- (2010) N R West et al. ONCOGENE
- Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer
- (2010) Satyendra Chandra Tripathi et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More